MariMed CEO Fireman to Highlight Progress at Two NYC Investor Conferences
- Tuesday, May 14, 2019 - Canaccord Genuity 3rd Annual Cannabis Conference; Grand Hyatt Hotel, New York, NY
- Wednesday, May 15th - CannaStocks 2019 Q1 Investor Conference; OTC Markets Group Headquarters, 300 Vesey Street, New York, NY
NORWOOD, MA, May 09, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB: MRMD) a leading multi-state cannabis and hemp operator in the US, announced today that MariMed CEO Bob Fireman will present at two cannabis investor conferences in New York City, May 14th and 15th.
On Wednesday, May 14th, MariMed CEO Bob Fireman will present a company overview at 3:20 PM at the Canaccord Annual Cannabis Conference at the Grand Hyatt in New York City.
On Thursday, May 15th, he will present an overview at 10:30 AM at the CannaStocks 2019 Q1 Investor Conference held at the OTC Markets Group headquarters at 300 Vesey Street in New York City.
MariMed CEO Bob Fireman noted, “MariMed has been moving quickly to leverage opportunities in both cannabis and hemp-based CBD markets in the US, Europe, and Latin America. We look forward to reviewing our progress at both cannabis investor events in New York."
About MariMed Inc.
MariMed, Inc. is dedicated to improving health and wellness with the highest quality hemp and cannabis products. The company offers a full range of cannabis products, operates state of the art cannabis dispensaries in six states, and has recently announced the formation of a separate division, MariMed Hemp, focused on the development of industrial hemp-derived CBD products. The Company made a major investment in Kentucky-based GenCanna USA, a national leader in the cultivation and processing of hemp and GMP compliant CBD products. Across its branded products, MariMed is in the forefront of precision dosed branded products for the treatment of specific symptoms and conditions. MariMed licenses and distributes its branded cannabis products in states where legal. MariMed will be distributing its CBD branded products across the country and abroad.
For additional information, visit www.MariMedAdvisors.com.
Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
Twitter: @MariMedInc Facebook: @MariMedInc Instagram: MariMedInc YouTube: MariMedInc
Forward Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected," “looks” or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.
Media: Julie Shepherd, Accentuate PR
Investors: Jon Levine, CFO, MariMed
Released May 9, 2019